Cuba Registers Cimavax EGF Vaccine for Lung Cancer
The vaccine passed several clinical tests and showed security and improvement in the quality of life of patients bearing some variants of these tumors.
FDA currenly introduced it in some trials, but they need 2-3 years of results. It seems that Canadians are more advanced in this vaccine approval.
The Cuban team claims that this vaccine could be effective against all cancer tumors. Learn more about
Cimavax EGF 
